Document Detail

Natriuretic peptides in the prognosis and management of acute coronary syndromes.
MedLine Citation:
PMID:  20700099     Owner:  NLM     Status:  MEDLINE    
Over the past decade, an evidence base has accumulated to support natriuretic peptide (NP) testing for diagnosis, risk assessment, and therapeutic monitoring and guidance of patients with heart failure. Investigators have also explored multiple other potential uses for these tests, including risk assessment of patients with suspected acute coronary syndromes (ACS). This article discusses the utility of NPs in the diagnosis and management of patients with ACS.
James A de Lemos; W Frank Peacock; Peter A McCullough
Related Documents :
14594879 - C reactive protein for risk stratification in acute coronary syndromes? verdict: unproven.
17186009 - Two cases of rapid onset parkinson's syndrome following toxic ingestion of ethylene gly...
19789699 - Thrombotic occlusion of the ostial left main coronary artery in a patient with acute co...
18311669 - Prasugrel, a third generation thienopyridine and potent platelet inhibitor.
14733789 - The role of inflammatory stress in acute coronary syndrome.
10949509 - A krimpsiekte-like syndrome in small stock poisoned by ornithogalum toxicarium archer &...
11681149 - An unusual cause of incontinence.
2268989 - The adult respiratory distress syndrome. definition and prognosis.
23393369 - Antioxidant effects of potassium ascorbate with ribose in costello syndrome.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Reviews in cardiovascular medicine     Volume:  11 Suppl 2     ISSN:  1530-6550     ISO Abbreviation:  Rev Cardiovasc Med     Publication Date:  2010  
Date Detail:
Created Date:  2010-08-11     Completed Date:  2010-10-19     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100960007     Medline TA:  Rev Cardiovasc Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  S24-34     Citation Subset:  IM    
Donald W. Reynolds Cardiovascular Research Center and Division of Cardiology, University of Texas Southwestern Medical Center, Dallas TX, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acute Coronary Syndrome / blood*,  diagnosis,  mortality,  therapy
Biological Markers / blood
Evidence-Based Medicine
Natriuretic Peptide, Brain / blood*
Peptide Fragments / blood
Predictive Value of Tests
Risk Assessment
Risk Factors
Treatment Outcome
Reg. No./Substance:
0/Biological Markers; 0/Peptide Fragments; 0/pro-brain natriuretic peptide (1-76); 114471-18-0/Natriuretic Peptide, Brain

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Differential diagnosis and overlap of acute chest discomfort and dyspnea in the emergency department...
Next Document:  Capturing the pathophysiology of acute coronary syndromes with circulating biomarkers.